---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-053419"
form_type: "8-K"
ticker: "ATEC"
cik: "0001350653"
company_name: "Alphatec Holdings, Inc."
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:08:55.603884+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ATEC raises FY2023 revenue guidance to ~$472M after Q3 preliminary revenue of $117.7-118.5M

## Summary
- Q3 total revenue $117.7-118.5M (+31-32% YoY), driven by lateral adoption momentum.
- Surgical revenue $103.3-103.9M; EOS revenue $14.3-14.5M.
- FY2023 revenue guidance raised to ~$472M from prior ~$462M.
- Preliminary results; final Q3 earnings expected Nov 6, 2023 after market close.

## SEC filing metadata
- accession: 0000950170-23-053419
- form_type: 8-K
- ticker: ATEC
- cik: 0001350653
- company_name: Alphatec Holdings, Inc.
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1350653/000095017023053419/0000950170-23-053419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1350653/000095017023053419/atec-20231016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-053419
- JSON: https://secwatch.observer/filing/0000950170-23-053419.json
- Plain text: https://secwatch.observer/filing/0000950170-23-053419.txt

## Key facts
- Earnings Releases
  Alphatec Holdings, Inc. reported third quarter ended September 30, 2023 results: revenue $117.7M to $118.5M. Guidance raised.
  - Period: third quarter ended September 30, 2023
  - Revenue: $117.7M to $118.5M
  - Guidance: raised
  - Result: preliminary results
  source text: Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today select preliminary financial results for the third quarter ended September 30, 2023, and updated full-year 2023 revenue guidance ahead of investor meetings scheduled during the 2023 North American Spine Society (NASS) Annual Meeting . Preliminary Third Quarter 2023 Revenue Ranges Quarter Ended September 30, 2023 Surgical Revenue $103.3M to $103.9M EOS Revenue $14.3M to $14.5M Total Revenue $117.7M to $118.5M
  evidence_url: https://www.sec.gov/Archives/edgar/data/1350653/000095017023053419/0000950170-23-053419-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.